1357348-22-1

Basic information

• Product Name: (2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate
• Synonyms: (2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate;(2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate(WX642106)
• CAS NO: 1357348-22-1
• Molecular Formula: C15H19NO5
• Molecular Weight: 293.31506
• Mol File: 1357348-22-1.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate(1357348-22-1)
• EPA Substance Registry System: (2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate(1357348-22-1)

Safety Data

• Hazardous Substances Data: 1357348-22-1(Hazardous Substances Data)

Usage

General Description

(2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate is a chemical compound with a complex molecular structure. It is classified as a piperidine derivative and belongs to the class of organic compounds known as esters. (2S)-1-Benzyl 2-Methyl 4-Hydroxypiperidine-1,2-Dicarboxylate is often used in the pharmaceutical industry as a building block for the synthesis of various drugs and medications. Its unique structure and properties make it suitable for use as a potential drug candidate in the treatment of certain medical conditions. However, like other chemicals, it should be handled and used with appropriate safety precautions due to its potential health hazards.

Upstream product

• 127474-54-8 (R)-2-(benzyloxycarbonylamino)pent-4-enoic acid 
• 127515-28-0 (R)-methyl 2-[N-(benzyloxycarbonyl)amino]-4-pentenoate 
• 50299-14-4 N-Acetyl-α-allylglycine 
• 475504-29-1 (2R)-4-formylpipecolic acid methyl ester 
• 475504-28-0 4-formyloxy-(S)-pipecolic acid methyl ester 
• 133192-44-6 methyl cis-4-hydroxy-2-piperidinecarboxylate 
• 501-53-1 benzyl chloroformate 
• 144913-66-6 4-hydroxy-2-piperidine carboxylic acid methyl ester 
• 211058-80-9 methyl 4(R)-hydroxypiperidine-2(S)-carboxylate 
• 403503-26-4 (2S,4R)-4-Hydroxy-1-((S)-1-phenyl-ethyl)-piperidine-2-carboxylic acid methyl ester 
• 403503-37-7 (2S,4R)-1-benzyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate 
• 78553-47-6 methyl (2S)-2-[N-(benzyloxycarbonyl)amino]pent-4-enoate 
• 78553-51-2 (S)-2-(benzyloxycarbonylamino)pent-4-enoic acid 
• 403503-40-2 (2S,4S)-4-Formyloxy-piperidine-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester 

Downstream Products

• 475504-32-6 (2R,4R)-4-hydroxypipecolic acid methyl ester 
• 845256-73-7 benzyl 4-[(tert-Butoxycarbonyl)(methyl)amino]-2-(hydroxymethyl)piperidine-1-carboxylate 

Relevant articles and documents

Inhibitors of influenza viruses replication

Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

MACROCYCLIC SERINE PROTEASE INHIBITORS

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

Use of hydrolases for the synthesis of cyclic amino acids

The synthesis of several cyclic amino acids that have all the necessary structural features to make them ideal scaffolds for use in medicinal chemistry is described. A key step in each synthesis is the use of hydrolase enzymes to define a chiral centre. I